Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Farnese, , Gastone,
DOB: 16-APR-1939 (Age: 86)
Gender: male
Address:
Rotonda Verdone, 9 Appartamento 6
35030 Galzignano Terme (Italy)
ID: 9783-008691-0 (ECI)
Report
Date: 27-NOV-2016
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Ospedali Riuniti Padova Sud "Madre Teresa di Calcutta"
Via Albere nan
35042 Este (Italy)
Specimen
Collected: 26-NOV-2016

Chemistry

Test 27-NOV-2016 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 241.1 H 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 109.8 0 - 199 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 156.0 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 63.1 40 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated total cholesterol and LDL cholesterol, both above recommended levels, which increases cardiovascular risk, especially at advanced age. Triglycerides and HDL cholesterol are within normal limits. Lipid-lowering therapy and lifestyle modifications should be considered in the clinical context.